Articles by tag: pharma-news

Islatravir: New HIV Pill Approved by FDA

FDA approved Idvynso (doravirine/islatravir) — the first two-drug regimen without INSTI and tenofovir. Learn why this is a new standard of therapy for aging HIV patients. Read details.

Subcutaneous Lecanemab: FDA Priority Status 2026

FDA extended review of subcutaneous Lecanemab for therapy initiation. Learn about the new standard of home Alzheimer's treatment and approval forecasts.

FDA to Review Generic Dexmethylphenidate CTx-1301

FDA to Rule on CTx-1301 May 31 — New ADHD Drug with Up to 12 Hours of Action Without Booster Doses. Learn How This Will Change Therapy for Children and Adults.

Lecanemab in Alzheimer's disease: 27% slowing

Lecanemab is the first drug with full FDA approval that slows cognitive decline by 27%. Learn about efficacy, risks, and therapy availability.